Literature DB >> 9922311

Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats.

H C Rath1, J S Ikeda, H J Linde, J Schölmerich, K H Wilson, R B Sartor.   

Abstract

BACKGROUND & AIMS: Recent data support an important role of resident luminal bacteria in experimental colitis. We determined how altered cecal bacterial loads influence colitis and gastritis.
METHODS: A cecal self-filling blind loop (SFBL) was created or the cecum was excluded from the fecal stream in specific pathogen-free HLA-B27 transgenic (TG) rats with early colitis and in nontransgenic (nonTG) littermates; controls underwent sham operation (SHAM). Luminal bacterial concentrations were determined by culture and counting chamber.
RESULTS: TG rats with SFBL had more severe cecal inflammation and leukocytosis than TG SHAM controls. TG excluded rats with low cecal bacterial loads had no cecal inflammation and less colitis and gastritis than SHAM controls, despite having normal distal colonic and gastric bacterial concentrations. Metronidazole attenuated cecal inflammation and eliminated Bacteroides in SFBL TG rats. NonTG SFBL rats had mild cecal inflammation and no gastritis and colitis. The ratio of total anaerobic to aerobic bacteria was 1000-fold greater in SFBL than in SHAM rats, with a 10,000-fold increased ratio of Bacteroides spp. to aerobes.
CONCLUSIONS: The luminal bacterial load and composition determines the activity of cecal inflammation in genetically susceptible hosts. Lowering cecal bacterial concentrations can diminish inflammation in remote organs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9922311     DOI: 10.1016/s0016-5085(99)70127-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  27 in total

Review 1.  Bacteria as the cause of ulcerative colitis.

Authors:  M Campieri; P Gionchetti
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

2.  Expression of intrinsic factor in rat and murine gastric mucosal cell lineages is modified by inflammation.

Authors:  J Shao; R B Sartor; E Dial; L M Lichtenberger; W Schepp; D H Alpers
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  Dendritic cells and the intestinal bacterial flora: a role for localized mucosal immune responses.

Authors:  Holm H Uhlig; Fiona Powrie
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

4.  Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats.

Authors:  L A Dieleman; F Hoentjen; B-F Qian; D Sprengers; E Tjwa; M F Torres; C D Torrice; R B Sartor; S L Tonkonogy
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

5.  Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved.

Authors:  Nadeem A Afzal; Sue Davies; Morine Paintin; Franck Arnaud-Battandier; John A Walker-Smith; Simon Murch; Robert Heuschkel; John Fell
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 6.  Immunogenetic phenotypes in inflammatory bowel disease.

Authors:  Marla-C Dubinsky; Kent Taylor; Stephan-R Targan; Jerome-I Rotter
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

Review 7.  Bacteria in the intestine, helpful residents or enemies from within?

Authors:  Geraldine O Canny; Beth A McCormick
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

8.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.

Authors:  S J Ott; M Musfeldt; D F Wenderoth; J Hampe; O Brant; U R Fölsch; K N Timmis; S Schreiber
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria.

Authors:  Sonia Pavan; Pierre Desreumaux; Annick Mercenier
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

10.  Fucoidan derived from Cladosiphon okamuranus Tokida ameliorates murine chronic colitis through the down-regulation of interleukin-6 production on colonic epithelial cells.

Authors:  S Matsumoto; M Nagaoka; T Hara; I Kimura-Takagi; K Mistuyama; S Ueyama
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.